- Type / Class
- Equity / Common Stock
- Shares outstanding
- 44,038,904
- Total 13F shares
- 47,221,203
- Share change
- -1,176,529
- Total reported value
- $1,439,219,439
- Price per share
- $30.47
- Number of holders
- 158
- Value change
- +$22,363,225
- Number of buys
- 104
- Number of sells
- 45
Quarterly Holders Quick Answers
What is CUSIP 08659B102?
CUSIP 08659B102 identifies BBNX - Beta Bionics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 08659B102:
Top shareholders of BBNX - Beta Bionics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
13D/G
|
Company |
11%
from 13D/G
|
4,957,252
|
$98,500,197 | — | 30 Sep 2025 | |
| Farallon Capital Partners, L.P. |
13D/G
|
Dapice Joshua J. |
9.9%
|
4,379,920
|
$88,211,589 | +$3,544,640 | 31 Dec 2025 | |
| Zone Healthcare Holdings, LLC |
13D/G
|
Dapice Joshua J. |
9.9%
|
4,313,920
|
$85,717,590 | +$17,618,729 | 30 Sep 2025 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
9.8%
|
4,313,920
|
$85,717,590 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
8.9%
|
3,901,599
|
$77,524,772 | — | 30 Sep 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
8.8%
|
3,870,158
|
$76,900,039 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
13D/G
|
Company |
8.6%
from 13D/G
|
3,761,583
|
$74,742,654 | — | 30 Sep 2025 | |
| Sands Capital Alternatives, LLC |
13F
|
Company |
8.1%
|
3,570,113
|
$70,938,145 | — | 30 Sep 2025 | |
| RTW INVESTMENTS, LP |
13F
13D/G
|
Company |
5.7%
from 13D/G
|
3,299,191
|
$65,554,925 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
6.4%
from 13D/G
|
2,781,331
|
$55,265,048 | — | 30 Sep 2025 | |
| Sands Capital Life Sciences Pulse Fund II, L.P. |
13D/G
|
— |
8.2%
|
3,570,113
|
$48,410,732 | +$5,636,946 | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5%
|
2,216,185
|
$44,035,595 | — | 30 Sep 2025 | |
| Omega Fund Management, LLC |
13F
|
Company |
4.4%
|
1,920,125
|
$38,152,884 | — | 30 Sep 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.7%
|
1,168,415
|
$23,216,406 | — | 30 Sep 2025 | |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
|
Company |
3.7%
|
1,593,608
|
$21,609,324 | $0 | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.4%
|
1,058,975
|
$21,041,833 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
917,553
|
$18,235,786 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.9%
|
826,302
|
$16,418,621 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
|
Company |
1.8%
|
796,964
|
$15,835,993 | -$29,602,207 | 30 Sep 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.5%
|
650,825
|
$12,931,893 | — | 30 Sep 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.4%
|
600,000
|
$11,922,000 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.4%
|
594,902
|
$11,820,702 | — | 30 Sep 2025 | |
| Walleye Capital LLC |
13F
|
Company |
1.3%
|
591,187
|
$11,746,886 | — | 30 Sep 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
487,658
|
$9,691,000 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.91%
|
399,253
|
$7,933,157 | — | 30 Sep 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.83%
|
364,448
|
$7,242,000 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.75%
|
330,692
|
$6,570,850 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.68%
|
298,060
|
$5,922,452 | — | 30 Sep 2025 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.64%
|
281,250
|
$5,588,438 | — | 30 Sep 2025 | |
| First Eagle Investment Management, LLC |
13F
|
Company |
0.53%
|
233,202
|
$4,633,724 | — | 30 Sep 2025 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.51%
|
222,615
|
$4,423,360 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.47%
|
205,955
|
$4,092,326 | — | 30 Sep 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.46%
|
204,292
|
$4,059,281 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.45%
|
197,707
|
$3,928,438 | — | 30 Sep 2025 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.45%
|
197,052
|
$3,915,423 | — | 30 Sep 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.42%
|
183,663
|
$3,649,382 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.37%
|
163,764
|
$3,253,991 | — | 30 Sep 2025 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.37%
|
162,649
|
$3,231,836 | — | 30 Sep 2025 | |
| Rakuten Investment Management, Inc. |
13F
|
Company |
0.08%
|
35,512
|
$2,699,622 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.29%
|
127,905
|
$2,541,472 | — | 30 Sep 2025 | |
| Longaeva Partners L.P. |
13F
|
Company |
0.28%
|
125,483
|
$2,493,347 | — | 30 Sep 2025 | |
| Kent Lake PR LLC |
13F
|
Company |
0.28%
|
125,000
|
$2,483,750 | — | 30 Sep 2025 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Company |
0.26%
|
114,666
|
$2,278,413 | — | 30 Sep 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.21%
|
94,227
|
$1,872,287 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.2%
|
90,118
|
$1,790,645 | — | 30 Sep 2025 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.19%
|
85,741
|
$1,703,674 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.17%
|
75,775
|
$1,506,000 | — | 30 Sep 2025 | |
| Meridiem Capital Partners LP |
13F
|
Company |
0.17%
|
73,386
|
$1,458,180 | — | 30 Sep 2025 | |
| Bellevue Group AG |
13F
|
Company |
0.15%
|
64,283
|
$1,277,303 | — | 30 Sep 2025 | |
| Legato Capital Management LLC |
13F
|
Company |
0.14%
|
63,625
|
$1,264,229 | — | 30 Sep 2025 |
Institutional Holders of Beta Bionics, Inc. - Common Stock (BBNX) as of Q4 2025
As of 31 Dec 2025,
Beta Bionics, Inc. - Common Stock (BBNX) was held by
158 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,221,203 shares.
The largest 10 holders included
EVENTIDE ASSET MANAGEMENT, LLC, FARALLON CAPITAL MANAGEMENT LLC, Sands Capital Alternatives, LLC, MORGAN STANLEY, BlackRock, Inc., Soleus Capital Management, L.P., RTW INVESTMENTS, LP, VANGUARD GROUP INC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, and Omega Fund Management, LLC.
This page lists
158
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
127
Q4 2025 holders
158
Holder diff
31
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.